Samrat Forgings manufactures closed-die steel forgings and precision machined components for the tractor, automotive, railway, and construction equipment industries.
The company lacks a durable moat, as evidenced by extremely thin average net margins of 1.3% and a high debt-to-equity ratio of 2.37. While they serve reputable OEMs, the low ROCE of 11.2% suggests they operate as a price-taking commodity supplier in a capital-intensive industry.
Management aggressively uses debt to fund capacity expansion, resulting in a strained balance sheet with high interest costs that consume a significant portion of operating profits. Reinvestment has led to revenue growth, but incremental returns on equity remain mediocre.
The company's aggressive debt-fueled expansion collided with a cyclical downturn in the industrial sector, causing interest obligations to overwhelm the razor-thin 1.3% net margins. As the interest coverage ratio of 1.75 collapsed, the high financial leverage of 2.37 D/E turned a minor revenue dip into a solvency crisis. The sudden resignation of both statutory and secretarial auditors in 2024 proved to be an early warning of internal control fragility, leading to a loss of creditor confidence and a permanent impairment of equity value as the business struggled to service its massive debt load.
RichFakir rates Samrat Forgings Ltd's business quality as poor — 40/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Samrat Forgings Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Samrat Forgings Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Samrat Forgings Ltd's fair value is about ₹85 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →